AI is playing an ever greater role in developing new medicines, as well as identifying new applications for existing drugs. French pharmaceutical company Sanofi announced Tuesday a partnership with ChatGPT-founder OpenAI and US biotech firm Formation Bio to accelerate the use of artificial intelligence in developing drugs. AI is playing an ever greater role in developing new medicines, as well as identifying new applications for existing drugs. It can be used for example to find new molecules more quickly and to improve clinical tests by vetting which patients would be Read More
No comments:
Post a Comment